The long term durability of combination antiretroviral therapy in HIV-positive patients across Europe
Despite dramatic improvements in the quantity and quality of life for Human Immunodeficiency Virus (HIV) positive people with the introduction of combination antiretroviral therapy (cART), all-cause mortality rates remain higher than the general population. Furthermore, treatment is a lifelong commi...
Main Author: | |
---|---|
Published: |
University College London (University of London)
2012
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.568271 |